⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) – Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Highlights Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Investors in MoonLake Immunotherapeutics (MLTX): Protect Your Rights - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Calls Attention to Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Urges MoonLake Immunotherapeutics (MLTX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
Securities Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Calls Attention to Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX